Skip to main navigation Skip to search Skip to main content

Differential optical imaging using vasoactive agents for cancer detection

  • Sanhita S. Dixit
  • , Kenneth T. Kotz
  • , Ashley D. Gibbs
  • , Juan M. Orduna
  • , Zishan Haroon
  • , Khalid Amin
  • , Gregory W. Faris

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Infrared transillumination is used to detect cancerous tissue in a human xenograft mouse model. Vasoactive agents are used to provide exogenous contrast by altering response from blood chromophores hemoglobin and oxyhemoglobin.

Original languageEnglish (US)
Title of host publicationBiomedical Optics, BIOMED 2008
StatePublished - Dec 1 2008
EventBiomedical Optics, BIOMED 2008 - St. Petersburg, FL, United States
Duration: Mar 16 2008Mar 19 2008

Other

OtherBiomedical Optics, BIOMED 2008
Country/TerritoryUnited States
CitySt. Petersburg, FL
Period3/16/083/19/08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Differential optical imaging using vasoactive agents for cancer detection'. Together they form a unique fingerprint.

Cite this